997
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept

ORCID Icon, , , &
Pages 413-417 | Received 02 Apr 2018, Accepted 16 May 2018, Published online: 28 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rémi Diesler & Vincent Cottin. (2022) Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies. Expert Review of Respiratory Medicine 16:5, pages 541-553.
Read now
Andreina Manfredi, Giulia Cassone, Fabrizio Luppi, Belen Atienza-Mateo, Alberto Cavazza, Nicola Sverzellati, Miguel A. González-Gay, Carlo Salvarani & Marco Sebastiani. (2021) Rheumatoid arthritis related interstitial lung disease. Expert Review of Clinical Immunology 17:5, pages 485-497.
Read now
A Manfredi, F Luppi, G Cassone, C Vacchi, C Salvarani & M Sebastiani. (2020) Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia. Expert Review of Clinical Immunology 16:8, pages 751-770.
Read now

Articles from other publishers (28)

Robert Harrington, Patricia Harkins & Richard Conway. (2023) Targeted Therapy in Rheumatoid-Arthritis-Related Interstitial Lung Disease. Journal of Clinical Medicine 12:20, pages 6657.
Crossref
Haoming Yuan, Shaoxin Cui, Lin Yang, Jiehan Cui, Xiaoping Wang, Meng Ding, Lu Jin, Yanru Wang, Fei Chang, Hongtao Jin, Jun Ma, Min Shi & Aijing Liu. (2023) Efficacy of non-conventional synthetic DMARDs for patients with rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. RMD Open 9:4, pages e003487.
Crossref
Xiao-Kai Chi, Xiao-Ling Xu, Bang-Yao Chen, Jin Su & Yong-Zhong Du. (2023) Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments. Journal of Nanobiotechnology 21:1.
Crossref
Anna Stainer, Antonio Tonutti, Maria De Santis, Francesco Amati, Angela Ceribelli, Gabriele Bongiovanni, Chiara Torrisi, Antonio Iacopino, Giuseppe Mangiameli, Stefano Aliberti & Carlo Selmi. (2023) Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review. Frontiers in Medicine 10.
Crossref
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón, María Correyero Plaza, Félix Manuel Francisco Hernández, María Vanesa Hernández Hernández & José Antonio Rodríquez Portal. (2022) SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatología Clínica (English Edition) 18:9, pages 501-512.
Crossref
Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón, María Correyero Plaza, Félix Manuel Francisco Hernández, María Vanesa Hernández Hernández & José Antonio Rodríquez Portal. (2022) Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 2: tratamiento. Reumatología Clínica 18:9, pages 501-512.
Crossref
Carmen Carrasco Cubero & Eugenio Chamizo Carmona. (2022) Answer to the Letter to the Editor: Methotrexate in interstitial lung disease associated with rheumatoid arthritis. Reumatología Clínica (English Edition) 18:7, pages 440-441.
Crossref
Luis Arboleya-Rodríguez & Miguel Arias-Guillén. (2022) Methotrexate in interstitial lung disease associated with rheumatoid arthritis. Reumatología Clínica (English Edition) 18:7, pages 441-442.
Crossref
Carmen Carrasco Cubero & Eugenio Chamizo Carmona. (2022) Respuesta a la carta al editor: Metotrexato en la neumopatía intersticial asociada a la artritis reumatoide. Reumatología Clínica 18:7, pages 440-441.
Crossref
Luis Arboleya-Rodríguez & Miguel Arias-Guillén. (2022) Metotrexato en la neumopatía intersticial asociada a la artritis reumatoide. Reumatología Clínica 18:7, pages 441-442.
Crossref
Kuang-Hui Yu, Hsin-Hua Chen, Tien-Tsai Cheng, Yeong-Jian Jan, Meng-Yu Weng, Yeong-Jang Lin, Hung-An Chen, Jui-Tseng Cheng, Kuang-Yung Huang, Ko-Jen Li, Yu-Jih Su, Pui-Ying Leong, Wen-Chan Tsai, Joung-Liang Lan & Der-Yuan Chen. (2022) Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis. Medicine 101:1, pages e28501.
Crossref
Carlos Fernández-Díaz, Belén Atienza-Mateo, Santos Castañeda, Rafael B Melero-Gonzalez, Francisco Ortiz-SanJuan, Javier Loricera, Ivette Casafont-Solé, Sebastián Rodríguez-García, Clara Aguilera-Cros, Ignacio Villa-Blanco, Enrique Raya-Alvarez, Clara Ojeda-García, Gema Bonilla, Alejandra López-Robles, Luis Arboleya, Javier Narváez, Evelin Cervantes, Olga Maiz, María N Alvarez-Rivas, Iván Cabezas, Eva Salgado, Cristina Hidalgo-Calleja, Sabela Fernández, Jesús C Fernández, Ivan Ferraz-Amaro, Miguel A González-Gay & Ricardo Blanco. (2022) Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis—multicentre study of 263 Caucasian patients . Rheumatology 61:1, pages 299-308.
Crossref
Marika Tardella, Marco Di Carlo, Marina Carotti, Andrea Giovagnoni & Fausto Salaffi. (2021) Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression. Clinical Rheumatology 40:12, pages 4861-4867.
Crossref
Javier Narváez, Teresa Otón, Jaime Calvo-Alén, Alejandro Escudero-Contreras, Santiago Muñoz-Fernández, José Manuel Rodríguez-Heredia, Susana Romero-Yuste, Paloma Vela-Casasempere, Sara Luján, Jose Luis Baquero & Loreto Carmona. (2021) Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey. Joint Bone Spine 88:4, pages 105172.
Crossref
Jacques Morel, Anne Tournadre, Jérémie Sellam, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle-Pensec, Philippe Dieudé, Philippe Goupille, Nicolas Kluger, Estibaliz Lazaro, Benoit Le Goff, Victor de Lédinghen, Thierry Lequerré, Gaëtane Nocturne, Raphaèle Seror, Marie-Elise Truchetet, Frank Verhoeven, Thao Pham & Christophe Richez. (2021) Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 88:4, pages 105221.
Crossref
Leticia Kawano-Dourado & Joyce S. Lee. (2021) Management of Connective Tissue Disease-Associated Interstitial Lung Disease. Clinics in Chest Medicine 42:2, pages 295-310.
Crossref
Jérémie Sellam, Jacques Morel, Anne Tournadre, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle-Pensec, Philippe Dieudé, Philippe Goupille, Denis Jullien, Nicolas Kluger, Estibaliz Lazaro, Benoit Le Goff, Victor de Lédinghen, Thierry Lequerré, Gaëtane Nocturne, Raphaèle Seror, Marie-Elise Truchetet, Frank Verhoeven, Thao Pham & Christophe Richez. (2021) Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI). Joint Bone Spine 88:2, pages 105174.
Crossref
Esteban Cano-Jiménez, Tomás Vázquez Rodríguez, Irene Martín-Robles, Diego Castillo Villegas, Javier Juan García, Elena Bollo de Miguel, Alejandro Robles-Pérez, Marta Ferrer Galván, Cecilia Mouronte Roibas, Susana Herrera Lara, Guadalupe Bermudo, Marta García Moyano, Jose Antonio Rodríguez Portal, Jacobo Sellarés Torres, Javier Narváez & María Molina-Molina. (2021) Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis. Scientific Reports 11:1.
Crossref
Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui & Shigeto Tohma. (2021) Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110225.
Crossref
Carlos Fernández-Díaz, Santos Castañeda, Rafael B Melero-González, Francisco Ortiz-Sanjuán, Antonio Juan-Mas, Carmen Carrasco-Cubero, Ivette Casafont-Solé, Alejandro Olivé, Samantha Rodríguez-Muguruza, Raquel Almodóvar-González, Raul Castellanos-Moreira, Sebastian C Rodríguez-García, Clara Aguilera-Cros, Ignacio Villa, Sergio Ordóñez-Palau, Erique Raya-Alvarez, Pilar Morales-Garrido, Clara Ojeda-García, Manuel J Moreno-Ramos, María Gema Bonilla Hernán, Iñigo Hernández Rodríguez, Mireia López-Corbeto, José L Andreu, Juan R D Jiménez de Aberásturi, Ana Ruibal-Escribano, Rosa Expósito-Molinero, Trinidad Pérez-Sandoval, Ana María López-Robles, Patricia Carreira-Delgado, Natalia Mena-Vázquez, Ana Urruticoechea-Arana, Cilia Peralta-Ginés, Luis Arboleya-Rodríguez, F Javier Narváez García, Deseada Palma-Sánchez, Evelin C Cervantes Pérez, Olga Maiz-Alonso, María N Alvarez-Rivas, Julia Fernández-Melón, Paloma Vela Casasempere, Ivan Cabezas-Rodríguez, Iván Castellvi-Barranco, Carmen González-Montagut, Juan Blanco-Madrigal, Natividad Del Val-Del Amo, María C Fito, Manuel Rodríguez-Gómez, Eva Salgado-Pérez, Blanca García-Magallón, Cristina Hidalgo-Calleja, Ruben López-Sánchez, Sabela Fernández-Aguado, Jesús C Fernández-López, Sonia Castro-Oreiro, Isabel Serrano-García, Andrea García-Valle, Susana Romero-Yuste, Lorena Expósito-Pérez, Lorena Pérez-Albadalejo, Angel García-Aparicio, Neus Quillis-Marti, José A Bernal-Vidal, Javier Loricera-García, José L Hernández, Miguel A González-Gay & Ricardo Blanco. (2020) Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients. Rheumatology 59:12, pages 3906-3916.
Crossref
Javier Narváez, Alejandro Robles-Pérez, Maria Molina-Molina, Vanesa Vicens-Zygmunt, Patricio Luburich, Marcos Anibal Yañez, Juan José Alegre & Joan M. Nolla. (2020) Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease. Seminars in Arthritis and Rheumatism 50:5, pages 902-910.
Crossref
Niranjan Jeganathan & Matheni Sathananthan. (2020) Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment. Lung 198:5, pages 735-759.
Crossref
Andreina Manfredi, Giulia Cassone, Federica Furini, Elisa Gremese, Vincenzo Venerito, Fabiola Atzeni, Eugenio Arrigoni, Giovanni Della Casa, Stefania Cerri, Marcello Govoni, Luca Petricca, Florenzo Iannone, Carlo Salvarani & Marco Sebastiani. (2020) Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study. Internal Medicine Journal 50:9, pages 1085-1090.
Crossref
Giulia Cassone, Andreina Manfredi, Caterina Vacchi, Fabrizio Luppi, Francesca Coppi, Carlo Salvarani & Marco Sebastiani. (2020) Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows. Journal of Clinical Medicine 9:4, pages 1082.
Crossref
Giulia Cassone, Andreina Manfredi, Fabiola Atzeni, Vincenzo Venerito, Caterina Vacchi, Valentina Picerno, Federica Furini, Gian Luca Erre, Paola Tomietto, Anna Laura Fedele, Giovanni Della Casa, Valeria Nucera, Chiara Giannitti, Carlo Salvarani & Marco Sebastiani. (2020) Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study. Journal of Clinical Medicine 9:1, pages 277.
Crossref
Zhaoyi Liu, Jie Shen, Zhouli Shen & Dongyi He. (2020) The clinical efficacy of traditional Chinese medicine in the treatment of rheumatoid arthritis with interstitial lung disease. Medicine 99:41, pages e22453.
Crossref
George E. Fragoulis, Elena Nikiphorou, Jörg Larsen, Peter Korsten & Richard Conway. (2019) Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment. Frontiers in Medicine 6.
Crossref
Adelle S. Jee & Tamera J. Corte. (2019) Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD). Drugs 79:14, pages 1511-1528.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.